Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Mabuka JM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fisher KL; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa., Mabuka JM; Africa Health Research Institute, University of KwaZulu-Natal, Durban, South Africa.; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa., Sivro A; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.; Department of Medical Microbiology, University of KwaZulu-Natal, Durban, South Africa., Ngcapu S; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.; Department of Medical Microbiology, University of KwaZulu-Natal, Durban, South Africa., Passmore JS; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.; Institute of Infectious Diseases and Molecular Medicine (IDM), University of Cape Town, and National Health Laboratory Service, Cape Town, South Africa., Osman F; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa., Ndlovu B; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa., Abdool Karim Q; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States., Abdool Karim SS; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States., Chung AW; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia., Baxter C; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.; Department of Public Health, University of KwaZulu-Natal, Durban, South Africa., Archary D; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.; Department of Medical Microbiology, University of KwaZulu-Natal, Durban, South Africa.
Publikováno v:
Frontiers in immunology [Front Immunol] 2020 Jul 06; Vol. 11, pp. 1274. Date of Electronic Publication: 2020 Jul 06 (Print Publication: 2020).
Autor:
Muema DM; Africa Health Research Institute, Durban, South Africa.; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Akilimali NA; Africa Health Research Institute, Durban, South Africa., Ndumnego OC; Africa Health Research Institute, Durban, South Africa., Rasehlo SS; Africa Health Research Institute, Durban, South Africa., Durgiah R; Africa Health Research Institute, Durban, South Africa., Ojwach DBA; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Ismail N; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Dong M; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Moodley A; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Dong KL; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.; Ragon Institute of MGH, MIT and Harvard University, Cambridge, MA, USA., Ndhlovu ZM; Africa Health Research Institute, Durban, South Africa.; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.; Ragon Institute of MGH, MIT and Harvard University, Cambridge, MA, USA., Mabuka JM; Africa Health Research Institute, Durban, South Africa., Walker BD; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.; Ragon Institute of MGH, MIT and Harvard University, Cambridge, MA, USA., Mann JK; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Ndung'u T; Africa Health Research Institute, Durban, South Africa. thumbi.ndungu@ahri.org.; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa. thumbi.ndungu@ahri.org.; Ragon Institute of MGH, MIT and Harvard University, Cambridge, MA, USA. thumbi.ndungu@ahri.org.; Max Planck Institute for Infection Biology, Berlin, Germany. thumbi.ndungu@ahri.org.; Division of Infection and Immunity, University College London, London, UK. thumbi.ndungu@ahri.org.
Publikováno v:
BMC medicine [BMC Med] 2020 Mar 25; Vol. 18 (1), pp. 81. Date of Electronic Publication: 2020 Mar 25.
Autor:
Chung AW; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, MA, USA.; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Australia., Mabuka JM; KwaZulu-Natal Research Institute for TB and HIV.; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal., Ndlovu B; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal., Licht A; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, MA, USA., Robinson H; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, MA, USA., Ramlakhan Y; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal., Ghebremichael M; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, MA, USA., Reddy T; Biostatistics Unit, Medical Research Council, Durban, South Africa., Goulder PJR; Department of Paediatrics, University of Oxford, Oxford OX1 3SY, UK., Walker BD; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, MA, USA.; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal., Ndung'u T; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, MA, USA.; KwaZulu-Natal Research Institute for TB and HIV.; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal.; Max Planck Institute for Infection Biology, Charitéplatz 1, 10117 Berlin, Germany., Alter G; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, MA, USA.
Publikováno v:
AIDS (London, England) [AIDS] 2018 Jun 19; Vol. 32 (10), pp. 1207-1217.
Autor:
Dong KL; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA; Infectious Disease Division, Massachusetts General Hospital, Boston, MA, USA., Moodley A; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Kwon DS; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA; Infectious Disease Division, Massachusetts General Hospital, Boston, MA, USA., Ghebremichael MS; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Dong M; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Ismail N; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Ndhlovu ZM; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Mabuka JM; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa; Africa Health Research Institute, University of KwaZulu-Natal, Durban, South Africa., Muema DM; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa; Africa Health Research Institute, University of KwaZulu-Natal, Durban, South Africa., Pretorius K; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Lin N; Infectious Disease Division, Massachusetts General Hospital, Boston, MA, USA., Walker BD; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA; Infectious Disease Division, Massachusetts General Hospital, Boston, MA, USA; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa; Institute for Medical Sciences and Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA., Ndung'u T; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa; Africa Health Research Institute, University of KwaZulu-Natal, Durban, South Africa; Max Planck Institute for Infection Biology, Berlin, Germany. Electronic address: ndungu@ukzn.ac.za.
Publikováno v:
The lancet. HIV [Lancet HIV] 2018 Jan; Vol. 5 (1), pp. e35-e44. Date of Electronic Publication: 2017 Oct 01.
Autor:
Mabuka JM; Africa Health Research Institute, Durban, South Africa.; HIV Pathogenesis Programme, Nelson R. Mandela School of Medicine, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, United States., Dugast AS; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, United States., Muema DM; Africa Health Research Institute, Durban, South Africa.; HIV Pathogenesis Programme, Nelson R. Mandela School of Medicine, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Reddy T; Biostatistics Unit, Medical Research Council, Durban, South Africa., Ramlakhan Y; Africa Health Research Institute, Durban, South Africa.; HIV Pathogenesis Programme, Nelson R. Mandela School of Medicine, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Euler Z; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, United States., Ismail N; HIV Pathogenesis Programme, Nelson R. Mandela School of Medicine, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Moodley A; HIV Pathogenesis Programme, Nelson R. Mandela School of Medicine, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, United States., Dong KL; HIV Pathogenesis Programme, Nelson R. Mandela School of Medicine, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, United States., Morris L; National Institute for Communicable Diseases, Johannesburg, South Africa.; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Walker BD; HIV Pathogenesis Programme, Nelson R. Mandela School of Medicine, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, United States.; Howard Hughes Medical Institute, Chevy Chase, MD, United States.; Institute for Medical and Engineering Sciences, Massachusetts Institute of Technology, Cambridge, MA, United States., Alter G; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, United States., Ndung'u T; Africa Health Research Institute, Durban, South Africa.; HIV Pathogenesis Programme, Nelson R. Mandela School of Medicine, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, United States.; Max Planck Institute for Infection Biology, Berlin, Germany.
Publikováno v:
Frontiers in immunology [Front Immunol] 2017 Sep 08; Vol. 8, pp. 1104. Date of Electronic Publication: 2017 Sep 08 (Print Publication: 2017).
Autor:
Kløverpris HN; KwaZulu-Natal Research Institute for Tuberculosis & HIV (K-RITH), University of KwaZulu-Natal (UKZN), 4001 Durban, South Africa; Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark. Electronic address: henrik.kloverpris@k-rith.org., Kazer SW; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139-4307, USA; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139-4307, USA; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA 02139-4307, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02139-4307, USA., Mjösberg J; Center for Infectious Medicine, Karolinska Institute, 171 76 Stockholm, Sweden., Mabuka JM; KwaZulu-Natal Research Institute for Tuberculosis & HIV (K-RITH), University of KwaZulu-Natal (UKZN), 4001 Durban, South Africa., Wellmann A; KwaZulu-Natal Research Institute for Tuberculosis & HIV (K-RITH), University of KwaZulu-Natal (UKZN), 4001 Durban, South Africa., Ndhlovu Z; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, UKZN, 4001 Durban, South Africa., Yadon MC; KwaZulu-Natal Research Institute for Tuberculosis & HIV (K-RITH), University of KwaZulu-Natal (UKZN), 4001 Durban, South Africa., Nhamoyebonde S; KwaZulu-Natal Research Institute for Tuberculosis & HIV (K-RITH), University of KwaZulu-Natal (UKZN), 4001 Durban, South Africa., Muenchhoff M; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, UKZN, 4001 Durban, South Africa; Department of Paediatrics, University of Oxford, Oxford OX1 3SY, UK., Simoni Y; Agency for Science, Technology and Research (A(∗)STAR), Singapore Immunology Network (SIgN), 138632 Singapore, Singapore., Andersson F; Department of Surgery, Inkosi Albert Luthuli Hospital, KwaZulu-Natal, 4058 Durban, South Africa., Kuhn W; ENT department Stanger Hospital, Stanger, KwaZulu Natal, 4450 Durban, South Africa., Garrett N; Department of Infectious Diseases, UKZN, 4001 Durban, South Africa; Center for the AIDS Programme of Research in South Africa - CAPRISA, 4001 Durban, South Africa., Burgers WA; Division of Medical Virology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, 7925 Cape Town, South Africa., Kamya P; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139-4307, USA; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, UKZN, 4001 Durban, South Africa., Pretorius K; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, UKZN, 4001 Durban, South Africa., Dong K; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139-4307, USA., Moodley A; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139-4307, USA., Newell EW; Agency for Science, Technology and Research (A(∗)STAR), Singapore Immunology Network (SIgN), 138632 Singapore, Singapore., Kasprowicz V; KwaZulu-Natal Research Institute for Tuberculosis & HIV (K-RITH), University of KwaZulu-Natal (UKZN), 4001 Durban, South Africa., Abdool Karim SS; Center for the AIDS Programme of Research in South Africa - CAPRISA, 4001 Durban, South Africa; Department of Epidemiology, Columbia University, New York, NY 10027, USA., Goulder P; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, UKZN, 4001 Durban, South Africa; Department of Paediatrics, University of Oxford, Oxford OX1 3SY, UK., Shalek AK; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139-4307, USA; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139-4307, USA; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA 02139-4307, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02139-4307, USA; Division of Health Sciences and Technology, Harvard Medical School, Boston, MA 02138, USA., Walker BD; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139-4307, USA; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, UKZN, 4001 Durban, South Africa; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA., Ndung'u T; KwaZulu-Natal Research Institute for Tuberculosis & HIV (K-RITH), University of KwaZulu-Natal (UKZN), 4001 Durban, South Africa; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139-4307, USA; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, UKZN, 4001 Durban, South Africa; Max Planck Institute for Infection Biology, 10117 Berlin, Germany., Leslie A; KwaZulu-Natal Research Institute for Tuberculosis & HIV (K-RITH), University of KwaZulu-Natal (UKZN), 4001 Durban, South Africa; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139-4307, USA.
Publikováno v:
Immunity [Immunity] 2016 Feb 16; Vol. 44 (2), pp. 391-405. Date of Electronic Publication: 2016 Feb 02.
Autor:
Lynch JB; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA., Nduati R, Blish CA, Richardson BA, Mabuka JM, Jalalian-Lechak Z, John-Stewart G, Overbaugh J
Publikováno v:
Journal of virology [J Virol] 2011 Jun; Vol. 85 (11), pp. 5252-61. Date of Electronic Publication: 2011 Mar 16.
Autor:
Katz DA; Department of Epidemiology, University of Washington, Seattle, WA 98104, USA. dkatz7@u.washington.edu, John-Stewart GC, Richardson BA, Majiwa M, Mabuka JM, Lohman-Payne B, Farquhar C
Publikováno v:
International journal of immunogenetics [Int J Immunogenet] 2010 Aug; Vol. 37 (4), pp. 301-5. Date of Electronic Publication: 2010 May 27.
Autor:
Lehman DA; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA., Chung MH, Mabuka JM, John-Stewart GC, Kiarie J, Kinuthia J, Overbaugh J
Publikováno v:
Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2009 Aug 15; Vol. 51 (5), pp. 522-9.